To explore whether the prognostic value of CLCA4 expression combined with serum AFP level was superior to AFP alone, all the HCC patients were divided into four subgroups according to the CLCA4 expression and serum AFP level. This evidence concerns the gene CLCA4 and hepatocellular carcinoma.